✦ LIBER ✦

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

✍ Scribed by Yung-Jue Bang; Young-Woo Kim; Han-Kwang Yang; Hyun Cheol Chung; Young-Kyu Park; Kyung Hee Lee; Keun-Wook Lee; Yong Ho Kim; Sang-Ik Noh; Jae Yong Cho; Young Jae Mok; Yeul Hong Kim; Jiafu Ji; Ta-Sen Yeh; Peter Button; Florin Sirzén; Sung Hoon Noh

Book ID: 117309624
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 258 KB
Volume: 379
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(11)61873-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-0007 * ADJUVANT CAPECITABINE AND OXALI

O-0007 * ADJUVANT CAPECITABINE AND OXALIPLATIN (XELOX) FOR GASTRIC CANCER AFTER D2 GASTRECTOMY: FINAL RESULTS FROM THE CLASSIC TRIAL

✍ Noh, S. H.; Park, S. R.; Yang, H.-K.; Chung, H. C.; Chung, I.-J.; Lee, K. H.; Ki 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 32 KB

Intraoperative versus extended antimicro

Intraoperative versus extended antimicrobial prophylaxis after gastric cancer surgery: a phase 3, open-label, randomised controlled, non-inferiority trial

✍ Hiroshi Imamura; Yukinori Kurokawa; Toshimasa Tsujinaka; Kentaro Inoue; Yutaka K 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 185 KB

Epirubicin, oxaliplatin, and capecitabin

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

✍ Waddell, Tom; Chau, Ian; Cunningham, David; Gonzalez, David; Okines, Alicia Fran 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 396 KB

Oxaliplatin, fluorouracil, and leucovori

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial

✍ Hong, Yong Sang; Nam, Byung-Ho; Kim, Kyu-pyo; Kim, Jeong Eun; Park, Seong Joon; 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 568 KB

Capecitabine and cisplatin with or witho

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

✍ Lordick, Florian; Kang, Yoon-Koo; Chung, Hyun-Cheol; Salman, Pamela; Oh, Sang Ch 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 323 KB

Adjuvant chemotherapy and timing of tamo

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial

✍ Kathy S Albain; William E Barlow; Peter M Ravdin; William B Farrar; Gary V Burto 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 145 KB